148 related articles for article (PubMed ID: 5322990)
21. A pilot study of AL-1021 in chronic schizophrenic patients.
Sugerman AA
Curr Ther Res Clin Exp; 1969 Dec; 11(12):775-8. PubMed ID: 4984042
[No Abstract] [Full Text] [Related]
22. Thiothixene versus trifluoperazine in newly-admitted schizophrenic patients.
Bishop MP; Fulmer TE; Gallant DM
Curr Ther Res Clin Exp; 1966 Nov; 8(11):509-14. PubMed ID: 4962777
[No Abstract] [Full Text] [Related]
23. A controlled clinical trial of trifluperidol on a group of chronic schizophrenic patients.
Menon MS; Ramachandran V
Curr Ther Res Clin Exp; 1972 Jan; 14(1):17-21. PubMed ID: 4621559
[No Abstract] [Full Text] [Related]
24. [Droperidol: a double-blind clinical study].
Cocchi A; Fonda P; Perosino N
Riv Sper Freniatr Med Leg Alien Ment; 1971 Dec; 95(6):1109-25. PubMed ID: 4947197
[No Abstract] [Full Text] [Related]
25. Relation of hypermagnesaemia to activity and neuroleptic drug therapy in schizophrenic states.
Brackenridge CJ; Jones IH
J Neurol Neurosurg Psychiatry; 1971 Apr; 34(2):195-9. PubMed ID: 5571604
[TBL] [Abstract][Full Text] [Related]
26. TRIFLUPERIDOL: A BUTYROPHENONE DERIVATIVE.
GALLANT DM; BISHOP MP; TIMMONS E; STEELE CA
Am J Psychiatry; 1963 Nov; 120():485-7. PubMed ID: 14051242
[No Abstract] [Full Text] [Related]
27. [Comparison of triperidol with perphenazine in schizophrenic psychoses. Effect on the photomyoclonic threshold].
Náhunek K; Hádlík J; Rodová A; Misurec J; Vanýsek J
Act Nerv Super (Praha); 1970 Jan; 12(1):56-7. PubMed ID: 4907390
[No Abstract] [Full Text] [Related]
28. A comparison of pimozide with perphenazine in the treatment of acute schizophrenic psychoses.
Svestka J; Náhunek K
Act Nerv Super (Praha); 1972; 14(2):93-4. PubMed ID: 4557145
[No Abstract] [Full Text] [Related]
29. Effects of melperone and thiothixene on prolactin levels in cerebrospinal fluid and plasma of psychotic women.
Bjerkenstedt L; Eneroth P; Härnryd C; Sedvall G
Arch Psychiatr Nervenkr (1970); 1977 Dec; 224(4):281-93. PubMed ID: 343747
[No Abstract] [Full Text] [Related]
30. Practical clinical psychopharmacology: the tranquilizers.
Snodgrass RE
J Indiana State Med Assoc; 1975 Oct; 68(10):883-7. PubMed ID: 1194695
[No Abstract] [Full Text] [Related]
31. [Therapeutic effect of triperidol].
Cwynar S; Pionkowski J; Tomczak W; Tyszka E
Psychiatr Pol; 1968; 2(6):627-32. PubMed ID: 5730286
[No Abstract] [Full Text] [Related]
32. Drug therapy.
Stone WN; Hofling CK; Winslow WW
Prog Neurol Psychiatry; 1968; 23():563-81. PubMed ID: 4890081
[No Abstract] [Full Text] [Related]
33. Loxapine: a controlled evaluation in chronic schizophrenic patients.
Bishop MP; Gallant DM
Curr Ther Res Clin Exp; 1970 Sep; 12(9):594-7. PubMed ID: 4989690
[No Abstract] [Full Text] [Related]
34. [Experience with the butyrophenone Luvatren in schizophrenia therapy].
Weiser G
Nord Psykiatr Tidsskr; 1968; 22(2):111-6. PubMed ID: 5704626
[No Abstract] [Full Text] [Related]
35. Management of the schizophrenic patient in a community psychiatric practice.
Tobin JM
Dis Nerv Syst; 1968 May; 29(5):Suppl:27-34. PubMed ID: 4876987
[No Abstract] [Full Text] [Related]
36. The clinical effects of intramuscular thiothixene and trifluoperazine in chronic schizophrenia: a comparative study.
Holden JM; Itil TM; Gannon PJ; Keskiner A
Curr Ther Res Clin Exp; 1971 May; 13(5):298-310. PubMed ID: 4998393
[No Abstract] [Full Text] [Related]
37. [Clinical neuroleptic tests in the case of the butyrophenone derivatives benzperidol and spiroperidol].
Haase HJ; Mattke D; Schönbeck M
Psychopharmacologia; 1964 Dec; 6(6):435-52. PubMed ID: 5830963
[No Abstract] [Full Text] [Related]
38. Effect of trifluperidol (R 2498) on the urinary elimination of bufotenin in schizophrenia.
Acebal EM; Spatz H
Int J Neuropsychiatry; 1967 Dec; 3(6):472-6. PubMed ID: 5583441
[No Abstract] [Full Text] [Related]
39. [Comparative study of thiothixene and trifluoperazine in schizophrencs in the acute phase].
Hillel JM; Albert JM; Tetreault L
Encephale; 1970; 59(2):162-79. PubMed ID: 5458711
[No Abstract] [Full Text] [Related]
40. An early clinical trial of lenperone (AHR 2277), a butyrophenone, in chronic schizophrenia.
Simpson GM; Varga V
Curr Ther Res Clin Exp; 1974 May; 16(5):477-82. PubMed ID: 4209063
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
